Orphan Drugs Need Separate Category In Medicare Formularies, BIO Says
Executive Summary
Orphan drugs should be guaranteed formulary coverage under Medicare Part D, the Biotechnology Industry Organization said in comments on the U.S. Pharmacopeia Medicare drug classification system